LIVER STIFFNESS AS A PREDICTIVE FACTOR FOR HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER SUSTAINED VIROLOGIC RESPONSE BY DIRECT-ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C

被引：0
|
作者：
Kawabe, Naoto [1 ]
Kuzuya, Teiji [1 ]
Hirooka, Yoshiki [1 ]
机构：
[1] Fujita Hlth Univ, Toyoake, Aichi, Japan
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2613
引用
收藏
页码：S1978 / S1978
页数：1
相关论文
共 50 条
  • [21] FACTORS ASSOCIATED WITH THE REDUCTION OF LIVER STIFFNESS AFTER THE TREATMENT OF DIRECT-ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C
    Kawabe, Naoto
    Takamura, Tomoki
    Nomura, Sayuri
    Mii, Arisa
    Fukui, Aiko
    Miyachi, Yohei
    Kurashita, Takamitsu
    Ochi, Yuka
    Ohki, Masashi
    Nakaoka, Kazunori
    Nakano, Takuji
    Nishikawa, Toru
    Osakabe, Keisuke
    Ichino, Naohiro
    Hashimoto, Senju
    Hirooka, Yoshiki
    Yoshioka, Kentaro
    HEPATOLOGY, 2019, 70 : 913A - 914A
  • [22] Liver Stiffness Evaluation in Chronic Hepatitis C Patients with Cirrhosis before and after Direct-Acting Antivirals
    Stasi, Cristina
    Brillanti, Stefano
    MICROORGANISMS, 2024, 12 (07)
  • [23] Is Sustained Virologic Response to Direct-acting Antivirals a Valid Surrogate Endpoint for Clinical Outcomes of Hepatitis C?
    Lok, Anna Suk-Fong
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (05) : 787 - 788
  • [24] PREDICTIVE FACTORS AND CLINICAL OUTCOME FOR LIVER STIFFNESS PROGRESSION AFTER DIRECT-ACTING ANTIVIRALS TREATMENT IN CHRONIC HEPATITIS C PATIENTS
    Liu, Yen-Chun
    Jeng, Wen-Juei
    Cheng, Ya-Ting
    Hsieh, Yi-Chung
    Chen, Yi-Cheng
    Lin, Chun-Yen
    Chien, Rong-Nan
    Tai, Dar-In
    Sheen, I-Shyan
    HEPATOLOGY, 2019, 70 : 920A - 921A
  • [25] Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antivirals
    Sanchez-Azofra, Maria
    Fernandez, Inmaculada
    Garcia-Buey, Maria L.
    Dominguez-Dominguez, Lourdes
    Fernandez-Rodriguez, Conrado M.
    Mancebo, Antonio
    Bonet, Lucia
    Ryan, Pablo
    Gea, Francisco
    Diaz-Sanchez, Antonio
    Garcia-Mayor, Marian
    Martin-Carbonero, Luz
    Castillo, Pilar
    Manzano, Maria L.
    Gonzalez-Moreno, Leticia
    Pulido, Federico
    Gutierrez, Maria L.
    Moreno, Jose M.
    Garcia-Amengual, Irene M.
    Cuevas, Guillermo
    Guerrero, Antonio
    Rivero-Fernandez, Miguel
    Portales, Maria E.
    Montes, Maria L.
    Olveira, Antonio
    LIVER INTERNATIONAL, 2021, 41 (12) : 2885 - 2891
  • [26] Fatty Liver Prevalence in Hepatitis C patients after Sustained Virological Response with Direct-Acting Antivirals
    Noureddin, Mazen
    Wong, Micaela
    Lu, Shelly C.
    Sanyal, Arun J.
    Mena, Edward A.
    HEPATOLOGY, 2017, 66 : 1139A - 1140A
  • [27] Regression of Liver Fibrosis Stage in Chronic Hepatitis C Infected Patients After Achieving Sustained Virologic Response Using Direct-Acting Antivirals as Demonstrated by Elastography
    Alawad, Ahmad S.
    Yoneda, Masato
    Grant, Tiffannia
    Thomas, Emmanuel
    Schiff, Eugene R.
    HEPATOLOGY, 2016, 64 : 404A - 405A
  • [28] RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C AND STAGE-3 LIVER FIBROSIS AFTER SUSTAINED VIROLOGICAL RESPONSE (SVR) WITH DIRECT-ACTING ANTIVIRALS (DAA)
    Sanchez-Azofra, Maria
    Fernandez, Inmaculada
    Luisa Garcia-Buey, Maria
    Dominguez, Lourdes
    Fernandez-Rodriguez, Conrado M.
    Moreno Planas, Jose Maria
    Bonet, Lucia
    Garcia Montes, Maria Luisa
    Ryan, Pablo
    Gea, Francisco
    Diaz Sanchez, Antonio
    Garcia-Mayor, Marian
    Luisa Manzano, Maria
    Gonzalez Moreno, Leticia
    Bisbal, Otilia
    Luisa Gutierrez, Maria
    Mancebo Martinez, Antonio
    Martin Carbonero, Luz
    Guerrero, Antonio
    Rivero, Miguel
    Elena Portales, Maria
    Castillo Grau, Pilar
    Olveira, Antonio
    HEPATOLOGY, 2020, 72 : 98A - 99A
  • [29] Prediction of Hepatocellular Carcinoma Development in Korean Patients after Hepatitis C Cure with Direct-Acting Antivirals
    Hong, Hyeyeon
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    GUT AND LIVER, 2024, 18 (01) : 147 - 155
  • [30] THROMBOSPONDIN-2 IS A PREDICTIVE BIOMARKER FOR HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER HEPATITIS C VIRUS ELIMINATION BY DIRECT-ACTING ANTIVIRALS
    Matsumae, Takayuki
    HEPATOLOGY, 2022, 76 : S350 - S350
12345